Article
Building a network of TP53 and IGHV testing reference centers across Spain: the Red53 initiative.
Annals of hematology - 1 Mar 2021
Bosch Francesc, Navarro Blanca, Crespo Marta, Alcoceba Miguel, Sánchez Julio Bravo, Tazón Barbara, Serrano Alicia, Álvarez María García, Serrano Lydia González, Alonso-Torres Pablo, Villanueva Miguel, Loriente Cristina, Abrisqueta Pau, Peiró Manel, García-Marco José Antonio, González Marcos, Terol María José
Abstract excerpt
Among the different biomarkers predicting response in chronic lymphocytic leukemia (CLL), the most influential parameters are the mutational status of the IGHV genes and the presence of TP53 gene disruptions. Nevertheless, these important assessments are not readily available in most centers dealing with CLL patients. To provide this molecular testing across the country, the Spanish Cooperative Group on CLL...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.